Navigation Links
SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil
Date:1/5/2011

STOUGHTON, Mass., Jan. 5, 2011 /PRNewswire/ -- SyncMedical LLC today announced that the Brazilian ANVISA (Agencia Nacional de Vigilancia Sanitaria – Brazilian National Health Surveillance Agency) has approved their Ethos Spine Pedicle Screw System for sale in Brazil. SyncMedical's Ethos Spine product line was developed to fulfill the need for quality and cost effective treatment solutions to surgeons in the ever-growing, ever-changing field of spine surgery. The Ethos Spine product line provides U.S. manufactured minimally invasive solutions to fit the needs of the global medical community. Ethos product offerings include the Ethos C-Spacer, the Ethos PEEK VBR System and the above mentioned Ethos Pedicle Screw System.

Earlier this month SyncMedical also received ANVISA approval for the Spirus Medical Endo-Ease Discovery System.  SyncMedical is the exclusive Latin American distributor for Spirus Medical, Inc. a core product line of SyncMedical's Internal Medicine Division.

Spirus Medical, Inc. is a leader in bringing novel innovations to the GI market. The company pioneered the concept of "spiral endoscopy" with the introduction of the Endo-Ease Discovery ® SB for deep enteroscopy and the Vista® Retrograde for colonoscopy and ileoscopy. These rotate-to-advance technologies utilize a spiral element on an over-tube to advance and anchor medical devices in natural orifices of the body or a surgically created opening. The company is presently developing a flexible endoscope with an integral drive to power a single use spiral component.

SyncMedical LLC

SyncMedical LLC is an affiliated company of STD Med, Inc. SyncMedical develops, produces and markets medical devices exclusively for regions outside of the United States by leveraging its strategic partnerships with industry leaders and medical professionals. SyncMedical is focused on developing access to the next generation of medical innovations. Our product development partners and our global team of representatives work together at every stage to provide solutions for the international medical community.

STD Med, Inc.

STD Med, Inc. is a rapidly growing and emerging leader in the development and manufacture of medical devices and precision machined components. Established in 1953, STD Med, Inc. is a privately held company. Over the past several years STD Med, Inc. has incubated and invested in several new technologies including Angiolink Corporation (acquired by Medtronic), Arthrosurface Inc., Spirus Medical, Inc. and Cardiosolutions, Inc. and it is our intention to continue to pursue disruptive innovation in the medical device marketplace.


'/>"/>
SOURCE SyncMedical LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
Breaking Medicine Technology:
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):